Neuraxpharm Group (Neuraxpharm), a leading European specialty pharmaceutical company focused on the treatment of central nervous system (CNS) disorders, marked the sixth anniversary since its ...

Dominic Walsh, a business reporter who previously covered the leisure and drinks industry for The Times from 1997 to 2024, stated in post to X: ...

VistaGen Therapeutics, Inc. (NASDAQ ... We encourage you to review the release and our 10-Q, which can be found in the Investors section of our website. We will make forward-looking statements ...

On Monday, TG Therapeutics Inc common stock (TGTX) stock saw a modest uptick, ending the day at $30.74 which represents a slight increase of $1.93 or 6.70% from the prior close of $28.81. The stock ...